Back

Eighteen-month changes in lipid management in the Veterans Affairs Lipid Optimization Reimagined Quality Improvement (VALOR-QI) Program

30 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Lipids (2) Lipids ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Rachel Ward

Veterans Health Administration Boston (VA Boston), Boston (United States of America)

7 More presentations in this session

Presentation thumbnail
Triple assessments of atherosclerosis in patients with heterozygous familial hypercholesterolemia
Doctor H. Tada (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Clinical relevance of the discordance between the Friedewald and Martin-Hopkins equations in the estimation of LDL-cholesterol in patients with acute coronary syndrome.
Doctor A. Meseguer Hernandez (Cartagena, ES)
Abstract Slides Video
Presentation thumbnail
Circulating Angiopoietin-like Protein 3 level and plaque calcification: insights from optical coherence tomography imaging analysis
Doctor Y. Kataoka (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Small for gestational age and lipid parameters during the first 14-16 months of life
Professor R. Frikke-Schmidt (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Cardiovascular risk among individuals with and without genetic mutation for familial hypercholesterolemia: A long-term follow-up study
Doctor R. Kirk Laursen (Aarhus, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids (2)

The Event

Event poster

ESC Congress 2025

30 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Long-term monitoring and follow up of cLDL levels and treatment adherence in low-risk ischemic heart disease patients discharged from the cardiac rehabilitation unit to primary care
30 August 2025
thumbnail
Congress Presentation
Unrealized opportunities for cardiovascular risk reduction with optimized statin and ezetimibe in veterans with coronary artery disease
28 August 2023
thumbnail
Congress Presentation
A randomized trial of a collaborative quality improvement strategy versus usual care for secondary prevention of cardiovascular diseases in India
1 September 2025
thumbnail
Congress Presentation
Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials
30 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources